Table 4.
NLR Low (≤5) | NLR High (>5) | HR (95% CI) * | p-Value | |
---|---|---|---|---|
Baseline | 29.9 (24.2–41.1) | 35.8 (16.8–NR) | 0.78 (0.37–1.6) | 0.50 |
At 12 weeks | 35.8 (29.9–NR) | 25.6 (16.2–NR) | 1.27 (0.62–2.61) | 0.51 |
* Hazard Ratio (HR) adjusted on docetaxel treatment, previous prostatectomy, Eastern Cooperative Group (ECOG) performance status, prostate specific antigen (PSA) level, hemoglobin level (Hb), total alkaline phosphatase (tALP).